Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1994-05-01

Acrolein genotoxicity in Drosophila melanogaster. III. Effects of metabolism modification.

A R Barros, L M Sierra, M A Comendador

Index: Mutat. Res. 321(3) , 119-26, (1994)

Full Text: HTML

Abstract

In order to investigate the role of metabolism in acrolein genotoxicity in D. melanogaster, the action of several metabolism modifiers, namely phenobarbital, an inducer of xenobiotic metabolism, phenylimidazole and iproniazid, inhibitors of oxidative activities of cytochrome P450, and diethyl maleate, a glutathione-depleting agent, have been assayed using the sex-linked recessive lethal (SLRL) test, with two different administration routes (feeding and injection). The results support the hypothesis that acrolein is not only a direct mutagen but is also transformed, by oxidative activities of cytochrome P450 after glutathione conjugation, into an active metabolite, possibly glycidaldehyde. Moreover, acrolein is deactivated by an enzymatic activity induced by phenobarbital.

Related Compounds

  • 1-Phenylimidazole

Related Articles:

Influence of inhibition of the metabolic activation on the mutagenicity of some nitrosamines, triazenes, hydrazines and seniciphylline in Drosophila melanogaster.

1988-11-01

[Mutat. Res. 202(1) , 251-67, (1988)]

Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles.

1993-05-05

[J. Biol. Chem. 268(13) , 9425-9, (1993)]

Three-dimensional pharmacophore hypotheses for the locust neuronal octopamine receptor (OAR3). Part 2: agonists.

1999-07-01

[Bioorg. Med. Chem. 7(7) , 1437-43, (1999)]

Chloroform-induced cytolethality in freshly isolated male B6C3F1 mouse and F-344 rat hepatocytes.

1998-04-01

[Toxicol. Appl. Pharmacol. 149(2) , 217-25, (1998)]

Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.

1996-07-23

[Biochemistry 35(29) , 9567-75, (1996)]

More Articles...